Leadless Electrocardiogram (ECG) Evaluation Study
Launched by MEDTRONIC BAKKEN RESEARCH CENTER · Feb 15, 2011
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
The leadless electrocardiogram (LECG) is a new technology incorporated into the Consulta CRT-P to obtain an ECG signal from the Consulta CRT-P similar to a surface ECG obtained from the device programmer (PECG) or an external ECG machine. The LECG signals are measured from three electrodes mounted on the outside of the pacemaker housing and provides an electrical far field signal of the electrical activity of the heart. The LECG provides three ECG channels as different projections of the electrical activity of the heart, similar to the surface ECG. Clinical interest of LECG is threefold. Fi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient with a CRT-P indication and
- • patient who has signed an informed consent form.
- Exclusion Criteria:
- • patient younger than 18 years and/or
- • unable to complete the 1-Month Follow-up visit and/or
- • legally incompetent or illiterate and therefore unable to provide an informed consent
About Medtronic Bakken Research Center
The Medtronic Bakken Research Center is a leading clinical trial sponsor dedicated to advancing medical technology and improving patient outcomes through innovative research and development. Situated at the forefront of healthcare innovation, the center focuses on pioneering solutions in areas such as cardiovascular, neurological, and diabetes care. With a commitment to rigorous scientific methodologies and collaboration with healthcare professionals, the Bakken Research Center drives clinical trials that contribute to evidence-based practices and the development of groundbreaking therapies. Its mission is to enhance the quality of life for patients worldwide through transformative medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Françoise HIDDEN-LUCET, MD
Principal Investigator
Hôpital La Pitié Salpêtrière, Paris, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials